DNA damage response and development of targeted cancer treatments

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Current anticancer treatments induce DNA damage but cause severe side effects due to lack of cancer cell specificity.
• The DNA damage response (DDR) pathway regulates cell fate (repair or apoptosis) based on DNA lesion severity.
• The DDR pathway can alert the innate immune system via NKG2D receptor ligands.

Purpose of the Study:

• To discuss the role of the DNA damage response in cancer therapy.
• To explore therapeutic strategies targeting the DDR pathway.
• To investigate the link between DDR and innate immune system activation.

Main Methods:

• Review of existing literature on DNA damage response and cancer therapy.
• Analysis of the mechanisms by which DDR influences cell fate and immune signaling.
• Discussion of potential therapeutic hypotheses targeting DDR components.

Main Results:

• Anticancer treatments inducing DNA damage activate the DDR.
• DDR can lead to cell cycle arrest, DNA repair, or apoptosis.
• DDR induces expression of ligands for the activating immune receptor NKG2D, alerting the innate immune system.

Conclusions:

• The DNA damage response plays a critical role in determining cancer cell fate.
• Targeting the DDR pathway presents a promising strategy for novel cancer therapies.
• Harnessing the DDR-mediated immune alert could enhance therapeutic efficacy and specificity.